Ligand-functionalized nanoliposomes for targeted delivery of galantamine.

[1]  V. Pillay,et al.  Surface-Engineered Nanoliposomes by Chelating Ligands for Modulating the Neurotoxicity Associated with β-Amyloid Aggregates of Alzheimer’s disease , 2012, Pharmaceutical Research.

[2]  G. De Rosa,et al.  Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent , 2012, International journal of nanomedicine.

[3]  Caragh S Murphy,et al.  Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. , 2011, Colloids and surfaces. B, Biointerfaces.

[4]  J. Li,et al.  In vitro and in vivo evaluation of sanguinarine liposomes prepared by a remote loading method with three different ammonium salts. , 2011, Die Pharmazie.

[5]  Viness Pillay,et al.  A Review on Composite Liposomal Technologies for Specialized Drug Delivery , 2011, Journal of drug delivery.

[6]  M. Nayak,et al.  Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents. , 2011, International journal of pharmaceutics.

[7]  Ming Yan,et al.  Protective effects of galantamine against Aβ-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress , 2010, Neurochemistry International.

[8]  Y. Perrie,et al.  Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent , 2010, The Journal of pharmacy and pharmacology.

[9]  H. Harashima,et al.  Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Robert J. Lee,et al.  Receptor-targeted nanocarriers for therapeutic delivery to cancer , 2010, Molecular membrane biology.

[11]  L. Borsig,et al.  Analysis of SM4 sulfatide as a P-selectin ligand using model membranes. , 2010, Biophysical chemistry.

[12]  Qiqing Zhang,et al.  Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[13]  Cuifang Cai,et al.  An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Yan Zhang,et al.  Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Sung Jin Park,et al.  Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  B. Austen,et al.  Galantamine inhibits β-amyloid aggregation and cytotoxicity , 2009, Journal of the Neurological Sciences.

[17]  F. Atyabi,et al.  Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel , 2009 .

[18]  M. Longo,et al.  Microbubbles coated with disaturated lipids and DSPE-PEG2000: phase behavior, collapse transitions, and permeability. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[19]  T. Honda,et al.  Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice , 2008, Clinical Cancer Research.

[20]  Zonghai Li,et al.  Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. , 2008, International journal of pharmaceutics.

[21]  John W. Park,et al.  Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. , 2008, Journal of pharmaceutical sciences.

[22]  G. Schenk,et al.  Drug targeting to the brain , 2008, Annual review of pharmacology and toxicology.

[23]  Ruili Huang,et al.  A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  H. Takeuchi,et al.  Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells. , 2008, International journal of pharmaceutics.

[25]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[26]  Kazuo Maruyama,et al.  Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. , 2008, International journal of pharmaceutics.

[27]  R. Marchant,et al.  Vesicle size and stability of biomimetic liposomes from 3'-sulfo-Lewis a (SuLea) containing glycolipids. , 2007, Colloids and surfaces. B, Biointerfaces.

[28]  K. Tanaka,et al.  Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[29]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[30]  W. Müller,et al.  Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.

[31]  Robert A Newman,et al.  Silk-fibroin-coated liposomes for long-term and targeted drug delivery , 2006, International journal of nanomedicine.

[32]  A. Delacourte.  Tauopathies: recent insights into old diseases. , 2006, Folia neuropathologica.

[33]  A. R. Kulkarni,et al.  Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[35]  Xuemei Liang,et al.  Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. , 2004, Journal of colloid and interface science.

[36]  M. Heinrich,et al.  Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. , 2004, Journal of ethnopharmacology.

[37]  P. R. Veerareddy,et al.  Lipid-based formulations of amphotericin B. , 2004, Drugs of today.

[38]  M. Chesler.  Regulation and modulation of pH in the brain. , 2003, Physiological reviews.

[39]  W. Pardridge,et al.  Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain. , 2003, Current opinion in drug discovery & development.

[40]  A. Fahr,et al.  Particle size of liposomes influences dermal delivery of substances into skin. , 2003, International journal of pharmaceutics.

[41]  T. Erkinjuntti.  Treatment options The latest evidence with galantamine (Reminyl®) , 2002, Journal of the Neurological Sciences.

[42]  M. Bally,et al.  Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol) , 2002, Bioscience reports.

[43]  L. Collins,et al.  A small, synthetic peptide for gene delivery via the serpin–enzyme complex receptor , 2001, The journal of gene medicine.

[44]  T. Okada,et al.  Preparation of functional liposomes with peptide ligands and their binding to cell membranes , 2000, Lipids.

[45]  P. Jallet,et al.  Early detection of liposome brain localization in rat experimental allergic encephalomyelitis , 1999, Experimental Brain Research.

[46]  E. Neuwelt,et al.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. , 1998, Neurosurgery.

[47]  J. C. Perales,et al.  Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. , 1997, The American journal of physiology.

[48]  D. Perlmutter,et al.  Specificity in Recognition of Amyloid-β Peptide by the Serpin-Enzyme Complex Receptor in Hepatoma Cells and Neuronal Cells (*) , 1995, The Journal of Biological Chemistry.

[49]  Y. Barenholz,et al.  Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.

[50]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[51]  G. Betageri,et al.  Drug encapsulation and release from multilamellar and unilamellar liposomes , 1992 .

[52]  D. Perlmutter,et al.  Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. , 1990, The Journal of biological chemistry.

[53]  D. Perlmutter,et al.  Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Dijkstra,et al.  Uptake and Intracellular Processing of Targeted and Nontargeted Liposomes by Rat Kupffer Cells In Vivo and In Vitro a , 1985, Annals of the New York Academy of Sciences.

[56]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[57]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Huwyler,et al.  Drug transport to brain with targeted liposomes , 2011, NeuroRX.

[59]  X. Ke,et al.  3つの異なるアンモニウム塩を用いたリモートローディング法によって調製したサンギナリンリポソームのin vitroとin vivoの評価 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2011 .

[60]  A. Kowalska.  [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease]. , 2004, Neurologia i neurochirurgia polska.

[61]  L. Rubin,et al.  The cell biology of the blood-brain barrier. , 1999, Annual review of neuroscience.

[62]  M. W. Hill,et al.  Preparation and Use of Liposomes as Models of Biological Membranes , 1974 .